Owusu, Ebenezer S. Adjah http://orcid.org/0000-0003-1206-6210
Samanta, Mayukh
Shaw, Jonathan E.
Majeed, Azeem
Khunti, Kamlesh
Paul, Sanjoy K.
Article History
Received: 10 December 2017
Revised: 15 March 2018
Accepted: 18 March 2018
First Online: 1 June 2018
Conflict of interest
: S.K.P. has acted as a consultant and speaker for Novartis, GI Dynamics, Roche, AstraZeneca, Guangzhou Zhongyi Pharmaceutical and Amylin Pharmaceuticals LLC. He has received grants in support of investigator and investigator-initiated clinical studies from Merck, Novo Nordisk, AstraZeneca, Hospira, Amylin Pharmaceuticals, Sanofi-Avensis, and Pfizer. J.E.S has received honoraria for advisory boards and lectures from AstraZeneca, BGP Products, Boehringer Ingelheim, Novartis, Janssen, Lilly, Novartis, Novo Nordisk, MSD, and Sanofi. K.K. has acted as a consultant, speaker or received funds for research from Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Janssen, Astra Zeneca and Boehringer Ingelheim, Roche and Servere. The other authors declare that they have no conflict of interest.